EUVIMEDTutustu EUVIMEDiin
Open access · CC BY 4.0

ACPGBI position statement on the role of standard high‐quality right hemicolectomy and complete mesocolic excision in right‐sided colon cancer

J D Mason iD, J S Khan, S Ahmed, P Coyne, J W Read, J Bundred, S J A Buczacki, A Harikrishnan, C Cunningham iD, Association of Coloproctology of Great Britain & Ireland (ACPGBI)

Colorectal Disease · 2026-05 · 28 (5)

DOI: 10.1111/codi.70495 ↗

At a glance

Journal article in Colorectal Disease, published online on 2026-05-22. Written by J D Mason and 9 co-authors. Institution: Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK. Major MEDLINE topics: Colectomy, Colonic Neoplasms, Mesocolon. Cited 3 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY 4.0).

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Background

Complete mesocolic excision (CME) has been proposed as a refinement of oncological surgery for right‐sided colon cancer, aiming to improve specimen quality, lymph node yield and oncological outcomes. However, its routine adoption remains controversial due to uncertainty regarding oncological benefit and concerns relating to technical complexity, training and service delivery. This position statement from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) examines the contemporary evidence surrounding CME and its role within modern management of right‐sided colon cancer.

Methods

This position statement was produced by the authors who represent a range of views on CME surgery. It synthesises contemporary evidence from large cohort studies, recent randomised control trials and international guidelines to evaluate the role of CME compared with standard high‐quality right hemicolectomy.

Results

CME is consistently associated with higher lymph node yields and improved specimen metrics, but studies demonstrating a definitive survival advantage remain limited. Randomised evidence does not support routine CME for all patients, although potential benefit exists in selected high‐risk groups. Recent evidence suggests that surgical plane quality, rather than the extent of lymphadenectomy, may be the principal determinant of oncological outcomes. CME is technically demanding and may carry increased procedural risks, particularly related to central vascular dissection, although these may be mitigated through structured training and optimised perioperative planning.

Conclusion

Routine use of CME for all right‐sided colon cancers is not supported by current evidence. Standard high‐quality right hemicolectomy should remain the default approach for most patients. Selective use of CME may be appropriate in physiologically fit patients with high‐risk or anatomically complex disease, delivered within experienced units with appropriate training, audit and quality assurance frameworks. Future progress will depend on standardisation of surgical technique, objective assessment of specimen quality and biologically tailored treatment strategies.

Subjects

MeSH terms (MEDLINE)

ColectomyColonic NeoplasmsMesocolonHumansLymph Node ExcisionUnited KingdomPractice Guidelines as Topic

Author keywords

complete mesocolic excisionlymph node yieldlymphadenectomyright‐sided colon cancerstandard mesocolic excision

Authors and institutions

  • Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
  • Department of Colorectal Surgery, Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Portsmouth, UK.
  • Faculty of Science and Health, University of Portsmouth, Portsmouth, UK.
  • Department of Colorectal Surgery, Liverpool University Hospitals NHS Foundation Trust, Royal Liverpool University Hospital, Liverpool, UK.
  • Department of Colorectal Surgery, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
  • Department of Colorectal Surgery, Royal Surrey NHS Foundation Trust, Royal Surrey County Hospital, Guildford, UK.

ORCID profiles: J D Mason, C Cunningham

Cite

APA

Mason, J. D., Khan, J. S., Ahmed, S., Coyne, P., Read, J. W., Bundred, J., Buczacki, S. J. A., Harikrishnan, A., Cunningham, C., & Association of Coloproctology of Great Britain & Ireland (ACPGBI) (2026). ACPGBI position statement on the role of standard high‐quality right hemicolectomy and complete mesocolic excision in right‐sided colon cancer. Colorectal Disease, 28(5). https://doi.org/10.1111/codi.70495

Vancouver

Mason JD, Khan JS, Ahmed S, Coyne P, Read JW, Bundred J, et al. ACPGBI position statement on the role of standard high‐quality right hemicolectomy and complete mesocolic excision in right‐sided colon cancer. Colorectal Disease. 2026;28(5). doi:10.1111/codi.70495

BibTeX
@article{Mason2026,
  author = {Mason, J D and Khan, J S and Ahmed, S and Coyne, P and Read, J W and Bundred, J and Buczacki, S J A and Harikrishnan, A and Cunningham, C and Association of Coloproctology of Great Britain & Ireland (ACPGBI), Association of Coloproctology of Great Britain & Ireland (ACPGBI)},
  title = {ACPGBI position statement on the role of standard high‐quality right hemicolectomy and complete mesocolic excision in right‐sided colon cancer},
  journal = {Colorectal Disease},
  year = {2026},
  volume = {28},
  number = {5},
  doi = {10.1111/codi.70495}
}
Start for free →